Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $383.83 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $122.70 | 2 | $0 (2017) |
| Lilly USA, LLC | $68.87 | 4 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $52.69 | 4 | $0 (2017) |
| Novo Nordisk Inc | $48.05 | 3 | $0 (2020) |
| Astellas Pharma US Inc | $32.17 | 2 | $0 (2019) |
| Gilead Sciences Inc | $20.36 | 1 | $0 (2017) |
| PFIZER INC. | $14.86 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $13.10 | 1 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $11.03 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $28.56 | 2 | Lilly USA, LLC ($15.46) |
| 2020 | $16.27 | 1 | Novo Nordisk Inc ($16.27) |
| 2019 | $59.86 | 4 | Novo Nordisk Inc ($31.78) |
| 2018 | $59.06 | 4 | Astellas Pharma US Inc ($16.88) |
| 2017 | $220.08 | 8 | Medtronic Vascular, Inc. ($122.70) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/24/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: RESPIRATORY | ||||||
| 01/28/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Diabetes | ||||||
| 02/16/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Diabetes | ||||||
| 12/06/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Diabetes | ||||||
| 10/26/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Diabetes | ||||||
| 02/06/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: UROLOGY | ||||||
| 01/16/2019 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Diabetes | ||||||
| 10/17/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: UROLOGY | ||||||
| 09/12/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $11.03 | General |
| Category: Cardiovascular | ||||||
| 09/05/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/11/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Diabetes | ||||||
| 12/22/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/21/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $20.36 | General |
| 10/10/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Diabetes | ||||||
| 06/28/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/11/2017 | Medtronic Vascular, Inc. | Micra (Device) | Food and Beverage | In-kind items and services | $102.58 | General |
| Category: Pacemakers | ||||||
| 05/11/2017 | Medtronic Vascular, Inc. | Micra (Device) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Pacemakers | ||||||
| 04/13/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/07/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 209 | 235 | $45,447 | $12,819 |
| 2021 | 11 | 569 | 735 | $111,138 | $55,147 |
| 2020 | 14 | 621 | 800 | $99,351 | $40,852 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 76 | 76 | $17,510 | $4,609 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 86 | $17,031 | $4,026 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 62 | $8,335 | $2,721 | 32.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 11 | 11 | $2,572 | $1,463 | 56.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 133 | 208 | $41,190 | $18,981 | 46.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 136 | 225 | $30,247 | $15,753 | 52.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 87 | 87 | $20,044 | $12,458 | 62.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 53 | 53 | $6,138 | $3,389 | 55.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $5,208 | $2,020 | 38.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 59 | 59 | $2,419 | $1,054 | 43.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 19 | 19 | $1,786 | $723.71 | 40.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 23 | 23 | $3,151 | $272.16 | 8.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 13 | 13 | $533.00 | $236.16 | 44.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 11 | 11 | $279.29 | $190.55 | 68.2% |
| 81002 | Urinalysis, manual test | Office | 2021 | 18 | 20 | $142.40 | $69.60 | 48.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 172 | 299 | $40,195 | $15,239 | 37.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 82 | 107 | $21,189 | $8,318 | 39.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 54 | 54 | $12,441 | $6,772 | 54.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 46 | 46 | $5,327 | $2,744 | 51.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $5,208 | $1,892 | 36.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 47 | 53 | $4,982 | $1,847 | 37.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 28 | 33 | $1,852 | $1,289 | 69.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 57 | 57 | $2,337 | $1,005 | 43.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 37 | 50 | $1,270 | $901.71 | 71.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 22 | 24 | $3,288 | $288.85 | 8.8% |
About Dr. Andrew Matthews, M.D
Dr. Andrew Matthews, M.D is a Internal Medicine healthcare provider based in Feasterville Trevose, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2008. The National Provider Identifier (NPI) number assigned to this provider is 1699935957.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Matthews, M.D has received a total of $383.83 in payments from pharmaceutical and medical device companies, with $28.56 received in 2022. These payments were reported across 19 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($383.83).
As a Medicare-enrolled provider, Matthews has provided services to 1,399 Medicare beneficiaries, totaling 1,770 services with total Medicare billing of $108,818. Data is available for 3 years (2020–2022), covering 29 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Feasterville Trevose, PA
- Active Since 06/11/2008
- Last Updated 07/01/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1699935957
Products in Payments
- Micra (Device) $122.70
- TRULICITY (Drug) $68.87
- XARELTO (Drug) $52.69
- Ozempic (Drug) $48.05
- MYRBETRIQ (Drug) $32.17
- CHANTIX (Drug) $14.86
- TRELEGY ELLIPTA (Drug) $13.10
- Livalo (Drug) $11.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Feasterville Trevose
Mr. Phillip Liaw, Md, MD
Internal Medicine — Payments: $3,813
Dr. Mark Mullen, Md, MD
Internal Medicine — Payments: $1,345
Leonid Magidenko, Md, MD
Internal Medicine — Payments: $1,112
Dr. Barbara Bix, Md, MD
Internal Medicine — Payments: $368.37
Dr. Larisa Khalupsky, M.d, M.D
Internal Medicine — Payments: $184.20
James Barnes, M.d, M.D
Internal Medicine